Startup · $3.2m raised · Healthcare
Melbourne based company improving clinical management and drug discovery for chronic respiratory diseases
Melbourne, VIC
Every investor coverage indicates participated in a round Diag-Nose.io raised.
| Investor | Rounds | Invested |
|---|---|---|
| Breakthrough Victoria | Seed | $800,000 |
| Carl Stubbings | Seed | - |
| Dr Richard Lipscombe | Seed | - |
| Radar Ventures | Seed | - |
| Specialty Physician Associates | Seed | - |
| Stephen Ho | Seed | - |
Companies Diag-Nose.io acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Carl Stubbings | Director | Startup Daily |
| Eldin Rostom | CEO and Co-founder (former) | Breakthrough Victoria (23 Dec 2025), Startup Daily (30 Oct 2025), SmartCompany, Startup Daily (25 Aug 2025), Breakthrough Victoria (17 Jun 2025), Startup Daily (31 Jan 2025) |
Stories naming Diag-Nose.io. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Breakthrough Victoria highlights portfolio achievements including Amber Electric's forty-five million dollar raise, Bygen and Diag-Nose grants, and Quantum Brilliance series A funding.
Also Breakthrough Victoria·Breakthrough Victoria·RenewEconomy·Startup Daily·RenewEconomy·Dealroom
Human Health, a Sydney patient-care platform built by two ex-Canva product leaders, has landed $8.5 million in a round led by LocalGlobe to expand across the US and UK.
Also Forbes Australia·Startup Daily·SmartCompany·Startup Daily
Two medical startups have received a $3 million federal CRC-P grant to build RhinoMAP, an AI tool giving clinicians earlier reads on whether respiratory treatments are working, with university and clinical partners.
Breakthrough Victoria profiles Diag-Nose.io chief executive Eldin Rostom, who describes the company's respiratory-disease diagnostics work and credits the investor's backing for building its lab, team and research scale.
Melbourne biotech Diag-Nose.io raised a seed round led by Breakthrough Victoria for its AI respiratory diagnostic, backed by physicians, funds and executives; one investor joins its board.
Roundup of six Australian and New Zealand startup raises totalling $63.5 million, covering in-store audio, EV charging, respiratory biotech, health AI, gig-economy fintech, and inclusive social media ventures.
Also Startup Daily
Breakthrough Victoria's update announces an $800,000 seed investment in Diag-Nose.io Medical, a Melbourne medtech whose RhinoMAP AI platform aids chronic respiratory disease drug research, supporting Victorian hiring and manufacturing growth.